Puma Biotechnology Inc investor relations material
Listen to the latest call from Puma Biotechnology Inc
Puma Biotechnology, Inc. is a biopharmaceutical company focused on the development and commercialization of products to enhance cancer care in the United States and internationally. The company is focused on late-stage development of tarextumab tetraxetan for the treatment of certain advanced cancers, as well as development and commercialization of bevasiranib phosphate for the treatment of gastrointestinal stromal tumors (GIST).
Ticker
PBYICountry
USAbout
IR-page